Kang B, Liu XY, Cheng YX, Tao W, Peng D. Factors associated with hypertension remission after gastrectomy for gastric cancer patients. World J Gastrointest Surg 2022; 14(8): 743-753 [PMID: 36157372 DOI: 10.4240/wjgs.v14.i8.743]
Corresponding Author of This Article
Dong Peng, PhD, Doctor, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China. carry_dong@126.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Case Control Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Bing Kang, Xiao-Yu Liu, Yu-Xi Cheng, Wei Tao, Dong Peng, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Bing Kang, Department of Clinical Nutrition, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Author contributions: Kang B and Liu XY contributed equally to this work; Tao W and Peng D contributed to conception and design of the study; all authors contributed to data collection; Cheng YX and Peng D contributed to the data analysis; Peng D led the quality assessments; Kang B and Liu XY write the origin draft; all the authors have agreed on the manuscript which will be submitted, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.
Institutional review board statement: This study was conducted in accordance with the World Medical Association Declaration of Helsinki and was approved by the Medical Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (2022-133-2).
Informed consent statement: This study is a retrospective study, and the patients is come from a teaching hospital of the First Affiliated Hospital of Chongqing Medical University. When we deliver the ethics application, we have also delivered application for exemption of informed consent, and This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (2022-133-2).
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The data of this study are available upon special request to the corresponding author(s).
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dong Peng, PhD, Doctor, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China. carry_dong@126.com
Received: April 3, 2022 Peer-review started: April 3, 2022 First decision: June 2, 2022 Revised: June 24, 2022 Accepted: August 5, 2022 Article in press: August 5, 2022 Published online: August 27, 2022 Processing time: 143 Days and 7.8 Hours
ARTICLE HIGHLIGHTS
Research background
Previous studies reported hypertension remission after gastrectomy for gastric cancer patients, and the remission rate was 11.1%-93.8%. We have reported the factors of hypertension remission previously, however, the follow-up time was six months. It is necessary to identify risk factors for hypertension for a relatively longer follow-up time.
Research motivation
The purpose of the current study was to analyze the predictive factors for hypertension remission one year after gastrectomy in gastric cancer patients.
Research objectives
The purpose of the current study is to analyze the predictive factors for hypertension remission one year after gastrectomy of gastric cancer patients and to construct a risk model for hypertension remission.
Research methods
Univariate and multivariate logistic regression of hypertension remission were conducted, and a nomogram model was established.
Research results
A total of 209 patients with concurrent gastric cancer and hypertension were included in the current study and the hypertension remission rate was 51.7% one year after gastrectomy. Younger age, higher weight loss and total gastrectomy were independent predictors for hypertension remission. The C-index of the model was 0.769 and the calibration curve suggested great agreement. Furthermore, decision curve analysis showed that the model was clinically useful.
Research conclusions
Younger age, higher weight loss and total gastrectomy were independent predictors for hypertension remission after gastrectomy for gastric cancer patients. The nomogram could visually display these results.
Research perspectives
Our study predicted that younger hypertension patients who underwent gastrectomy for gastric cancer might decrease anti-hypertensive medication and relieve hypertension-related comorbidities.
